wish to report the extension of the technology to the purine
bases dA and dG.
7-iodo-2′-deoxyguanosine 4 was synthesized in 10 steps
according to literature procedures.14 Sonogashira coupling
of 4 with 1-TMS-protected 1,7-octadiyne gave the key
intermediate 5 in good yield. After deprotection of the alkyne
and cleavage of the sugar protecting groups to 6, the
monomer was successfully converted into triphosphate 7,15
suitable for enzymatic incorporation.
In order to limit structural perturbation of the DNA duplex
to a minimum, we placed the alkyne group in the major
groove.6,12 To achieve this, we prepared the alkyne-bearing
derivatives of the 7-deazapurine bases 7-deaza-dA and
7-deaza-dG (Figure 1). The adenine building block was
To examine how the triphosphates 3 and 7 are accepted
by polymerases, we first performed primer extension studies.
To this end, a fluorescently labeled primer was hybridized
to a 30mer template. The elongation of the primer was
followed using PAGE. In the initial test runs, we used two
different templates containing each of the canonical bases
at least one time.16 As expected from literature precedents,6
the unnatural alkyne-bearing purines 3 and 7 were able to
fully replace the canonical bases dA and dG in typical primer
extension experiments. In further experiments, we could also
replace the nucleobases dT and dC by the alkyne-modified
bases 9 and 11, allowing us to prepare a DNA derivative in
which each nucleobase carries an alkyne-bearing functional
group. In all cases, we obtained a clean, full-length product,
proving that all triphosphates were efficiently incorporated
(Supporting Information).
Encouraged by this result, we started to incorporate our
building blocks 3 and 7 using PCR. To this end, we used a
300mer template DNA to create two modified DNA strands,
DNA300‚2 (dATP replaced by 3) and DNA300‚6 (dGTP
replaced by 7). Detection of the PCR products obtained with
the building block 7 turned out to be difficult because the
ethidium bromide fluorescence is typically quenched by
deazapurine derivatives.17 We found that the PCR product
DNA300‚2, however, was stainable with ethidium bromide
and also with SYBR green. Detection of DNA300‚6 required
the use of a fluorescein-labeled primer strand. With the help
of the KOD XL polymerase, we could indeed prepare
DNA300‚2 and DNA300‚6 efficiently without the use of any
additives (Figure 2). The obtained amplicons comprise 170
(DNA300‚2) or 103 (DNA300‚6) alkynes attached to the
purine bases. Simple screenings of the different temperature
steps (annealing, elongation, and denaturation) of the PCR
cycle were sufficient to achieve this goal. An attempted PCR
incorporation of all four alkyne-modified triphosphates into
a 300mer DNA unfortunately failed. In order to investigate
the structure of the modified DNA in more detail, we
performed UV and CD measurements (Supporting Informa-
tion). Both DNA strands exhibited an additional absorption
band at longer wavelengths due to conjugation of the
nucleobase to the internal alkyne. This observation is in
accord with previous results obtained by us.11 This additional
Figure 1. Syntheses of the triphosphates 3 and 7. The alkyne-
bearing pyrimidine triphosphates 9 and 11 as well as the galactose
azide 12 were reported previously.
synthesized by a Sonogashira coupling on the unprotected
7-deaza-7-iodo-2′-deoxyadenosine 1 to give the free nucleo-
side 2.13,14 The synthesis of the triphosphate 3 was achieved
by the method of Kovacs et al.15 The corresponding 7-deaza-
(9) (a) Huisgen, R. 1,3-Dipolar Cycloaddition Chemistry; Wiley: New
York, 1984; pp 1-176. (b) Tornoe, C. W.; Christensen, C.; Meldal, M. J.
Org. Chem. 2002, 67 (9), 3057-3064. (c) Kolb, H. C.; Finn, M. G.;
Sharpless, K. B. Angew. Chem., Int. Ed. 2001, 40, 2004-2021.
(10) (a) Gierlich, J.; Burley, G. A.; Gramlich, P. M. E.; Hammond, D.
M.; Carell, T. Org. Lett. 2006, 8 (17), 3639-3642. (b) Burley, G. A.;
Gierlich, J.; Mofid, M. R.; Nir, H.; Tal, S.; Eichen, Y.; Carell, T. J. Am.
Chem. Soc. 2006, 128 (5), 1398-1399.
(13) (a) Seela, F.; Zulauf, M. Synthesis 1996, 726-730. (b) Seela, F.;
Sirivolu, V. R., Chem. BiodiVersity 2006, 3, 509-514.
(14) (a) Davoll, J. J. Chem. Soc. 1960, 1960, 130-138. (b) Buhr, C. A.;
Wagner, R. W.; Grant, D.; Froehler, B. C. Nucleic Acids Res. 1996, 24
(15), 2974-2980.
(15) Kovacs, T.; O¨ tvo¨s, L. Tetrahedron Lett. 1988, 29 (36), 4525-4528.
(16) Held, H. A.; Benner, S. A. Nucleic Acids Res. 2002, 30 (17), 3857-
3869.
(11) Gierlich, J.; Gutsmiedl, K.; Gramlich, P. M. E.; Schmidt, A.; Burley,
G.; Carell, T. Chem.sEur. J. 2007, 13, 9486-9494.
(17) (a) Li, H.; Seela, F. Nucleosides Nucleotides 2005, 24 (5-7), 865-
868. (b) Weiss, J.; Zucht, H.-D.; Forssmann, W.-G. PCR Methods Appl.
1994, 4, 124-125. (c) Latimer, L. J. P.; Lee, J. S. J. Biol. Chem 1991, 266
(21), 13849-13851.
(12) Capek, P.; Cahova´, H.; Pohl, R.; Hocek, M.; Gloeckner, C.; Marx,
A. Chem.sEur. J. 2007, 13, 6196-6203.
250
Org. Lett., Vol. 10, No. 2, 2008